Davor Miličić

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Inflammation, Allergy, Lung Inflammation +11

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

Kornelia Kotseva, David Wood, Dirk De Bacquer et al. · European Journal of Preventive Cardiology · 2015 · 985 citations · Full text

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

Kornelia Kotseva, Guy De Backer, Dirk De Bacquer et al. · European Journal of Preventive Cardiology · 2019 · 887 citations · Full text

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Paul M. Ridker, Jean MacFadyen, Peter Libby et al. · The Lancet · 2017 · 847 citations · Full text

Cardiovascular Toxicity, C-reactive Protein Reduction, Cardiovascular Disease +8

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker et al. · The Lancet · 2020 · 723 citations · Full text

Heart Failure, Iron Metabolism, Clinical Nutrition +5